Purple Biotech Market Cap

Purple Biotech has a market cap or net worth of 18.58 million as of March 9, 2026. Its market cap has decreased by -43.33% in one year.

Market Cap

18.58M

Enterprise Value

-15.04M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

1.00

Market Cap Chart

Since July 14, 2013, Purple Biotech's market cap has increased from 17.87M to 18.58M, an increase of 3.98%. That is a compound annual growth rate of 0.31%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	18.58M	-16.67%
Dec 31, 2025	22.30M	-44.71%
Dec 31, 2024	40.34M	-48.30%
Dec 31, 2023	78.02M	-17.30%
Dec 29, 2022	94.35M	-55.64%
Dec 30, 2021	212.71M	-1.36%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Can-Fite BioPharma	19.70M
XTL Biopharmaceuticals	19.87M
Evogene	21.42M
BioLight Life Sciences	31.31M
BioLineRx	39.16M
Clal Biotechnology Industries	46.43M
Matricelf	146.87M
Geffen Residence & Renewal	277.04M

Market Cap Rankings